Manufacturing and Production

Showing 15 posts of 5863 posts found.

mylan

Mylan’s pathway to launch of biosimilar to Herceptin cleared by Roche

March 13, 2017 Manufacturing and Production, Sales and Marketing Genentech, Herceptin, Mylan, Roche, biosimilar

Mylan scored a big victory in its plan to launch its biosimilar to Roche’s blockbuster, Herceptin, after Roche and itself …
shutterstock_141299494

Immunotherapy: The three major treatments that are changing cancer prognoses

March 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …
oxford-biodynamics-logo

Oxford BioDynamics installs new SVP of Commercial Development

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioDynamics

Oxford BioDynamics, a biotech focused on the discovery and development of novel epigenetics biomarkers, has announced the appointment of Martin …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The past week in the industry has brought much hope for patients with the news of significant research data developments …

Closure of Scottish J&J plant threatens 400 staff

March 10, 2017 Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson

Johnson & Johnson has announced its intention to shut down its surgical suture manufacturing facility in Livingston, Scotland which sees …
thomas_headshot

BMS finds replacement for retiring CSO

March 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb

Bristol-Myers Squibb has announced the appointment of Dr. Thomas J. Lynch, Jr., to the position of Executive Vice President and …
facilities_lg06

13 FDA observations on Dr Reddy’s plant send shares to 3 year low

March 9, 2017 Manufacturing and Production Dr Reddy's, FDA

Indian pharmaceutical firm Dr Reddy’s has seen its shares drop on the Bombay Stock Exchange to their lowest point in …
trevor-philips

Vectura’s COO set to step down

March 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
gdd_logo_002

BeiGene to develop $330 million biologics plant

March 7, 2017 Manufacturing and Production, Research and Development BeiGene, China, Guangzhou

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …
shutterstock_38078521

Researchers discover worrying new antibiotic-resistance gene variant

March 7, 2017 Manufacturing and Production, Research and Development drug resistance

A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …
shutterstock_92671375

Cadila and Supernus settle patent dispute over epilepsy generic

March 7, 2017 Manufacturing and Production, Sales and Marketing Cadila, Supernus, Trokendi XR, Zydus Cadila

A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for …

Merck’s Allergopharma opens €42m biopharmaceutical plant

March 7, 2017 Manufacturing and Production Allergopharma, Merck

Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open …
bernie_2

Vermont senators call for restraints on “beautiful” pharma advertising

March 6, 2017 Manufacturing and Production, Sales and Marketing Bernie Sanders, Vermont, pricing

Bernie Sanders is yet again leading the charge against US pharma as Vermont senators have rallied against advertising and marketing …
sink

FDA approves first treatment for excessive night-time urination

March 6, 2017 Manufacturing and Production FDA, Noctiva, Serenity

The FDA has approved Noctiva, administered as a nasal spray, for the treatment of people suffering from nocturnal polyuria – …
The Gateway to Local Adoption Series

Latest content